Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on LinkedIn:
“Sarcoma is rare and complex. That’s why it’s critical to seek care at a place like Moffitt Cancer Center, where experts like John E. Mullinax are leading research into promising approaches like TIL therapy. Grateful for the groundbreaking work happening in our labs and clinics. ”
Proceed to the video attached to the post.
Read more Sarcoma’s Types, Success Rate, Side Effects And More.